GlobalData on MSN
Beacon of hope for XLRP patients on Phase III gene therapy success
Beacon states this is the first pivotal XLRP trial to meet its primary endpoint.
Like a delivery driver navigating crowded city streets, a gene-therapy-toting lipid nanoparticle faces a gauntlet of potential detours on its journey toward a cell's nucleus. First, there's entering ...
The US Food and Drug Administration on Thursday approved the first gene therapy for inherited hearing loss, a one-time treatment that proved to be life-changing for a small number of children in a ...
Gene Therapy Remains Top-of-Mind in Hemophilia Despite Recent Market Contraction, as Physicians and Patients Raise the Bar for Success ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results